Understanding the molecular basis and the role of risk factors in Coronavirus infection (SARS-CoV-2 or COVID-19) in preclinical models

  • Funded by Fundação de Amparo à Pesquisa do Estado de São Paulo [São Paulo Research Foundation] (FAPESP)
  • Total publications:3 publications

Grant number: 2020/04746-0

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2022
  • Known Financial Commitments (USD)

    $32,119.5
  • Funder

    Fundação de Amparo à Pesquisa do Estado de São Paulo [São Paulo Research Foundation] (FAPESP)
  • Principal Investigator

    Daniel Martins-de-Souza
  • Research Location

    Brazil
  • Lead Research Institution

    Universidade Estadual de Campinas
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen morphology, shedding & natural history

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Rapidly, SARS-CoV-2 viral infections took on pandemic dimensions, leading several countries to a state of public calamity. Using a methodology not directed by hypothesis, based on proteomic and metabolomic analyzes, the present project aims to identify the molecular mechanisms involved in SARS-CoV-2 infection in macrophage cultures, pulmonary epithelium as well as neurons and astrocytes. We will also investigate tissues from preclinical models such as brain, lung and bronchoalveolar lavage. We intend to provide clarifications about SARS-CoV-2 infection, proposing new therapeutic targets that can bring better perspectives regarding the spread of the disease and, consequently, provide an improvement in the quality of life of infected individuals.

Publicationslinked via Europe PMC

Diving into the proteomic atlas of SARS-CoV-2 infected cells.

Impact of Microbiota Depletion by Antibiotics on SARS-CoV-2 Infection of K18-hACE2 Mice.

Human disease biomarker panels through systems biology.